Can we quantify the quality of vision?

Article

The age of refractive surgery has introduced new aberrations to the human eye that require a shift in how visual performance is evaluated, said Ray Applegate, MD. Mesopic low contrast acuity best quantifies vision quality; it overcomes the weaknesses of other metrics and it can predict visual function among individuals.

The age of refractive surgery has introduced new aberrations to the human eye that require a shift in how visual performance is evaluated, said Ray Applegate, MD. Mesopic low contrast acuity best quantifies vision quality; it overcomes the weaknesses of other metrics and it can predict visual function among individuals.

Dr Applegate recruited 168 people with 6/6 or better vision across a range of ages and conducted a photopic high-contrast logMAR acuity test. "The test could only account for around 4% of the variation in our sample," he said. "We can't use it to predict the visual function of individuals. However mesopic low-contrast logMAR acuity accounted for a much broader range of the variation."

Dr Applegate said high contrast acuity is a poor metric because it is conducted under high luminance conditions and has excess contrast allowing a loss in contrast and image fidelity without a loss in measured acuity.

Contrast sensitivity, on the other hand, is impractical because it requires measurements along many different orientations. "That is simply not practical in the clinical environment and it is totally insensitive to phase shifts," insisted Applegate.

But mesopic low contrast acuity allows a large physiologic pupil and is sensitive to phase shifts and contrast loss. "It's also a recognition task as opposed to a detection task that's understood by clinicians and patients and it's easy to administer in a clinical setting," he said.

The study will be published shortly in Optometry and Vision Science.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.